​

Hims & Hers Health (HIMS) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

HIMS Stock Forecast

Hims & Hers Health (HIMS) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $39.00, with a high of $68.00 and a low of $21.00. This represents a 11.30% increase from the last price of $35.04.

$5 $18 $31 $44 $57 $70 High: $68 Avg: $39 Low: $21 Last Closed Price: $35.04

HIMS Stock Rating

Hims & Hers Health stock's rating consensus is Hold, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (42.86%), 7 Hold (50.00%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Hold
Total 14 0 1 7 6 Strong Sell Sell Hold Buy Strong Buy

HIMS Price Target Upside V Benchmarks

TypeNameUpside
StockHims & Hers Health11.30%
SectorConsumer Defensive Stocks 8.69%
IndustryHousehold & Personal Products Stocks 9.51%

Price Target Trends

1M3M12M
# Anlaysts-117
Avg Price Target-$68.00$24.29
Last Closing Price$35.04$35.04$35.04
Upside/Downside-94.06%-30.68%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 251471114
Mar, 252471115
Feb, 252361113
Jan, 252371114
Dec, 24237-113
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 19, 2025Maria RippsCanaccord Genuity$68.00$68.74-1.08%94.06%
Dec 02, 2024Maria RippsCanaccord Genuity$38.00$30.8123.34%8.45%
Nov 05, 2024Korinne WolfmeyerPiper Sandler$21.00$20.641.74%-40.07%
Nov 05, 2024Ryan MacDonaldNeedham$28.00$20.9633.59%-20.09%
Oct 29, 2024Michael ChernyLeerink Partners$26.00$23.0812.65%-25.80%
Oct 21, 2024Michael ChernyBank of America Securities$25.00$22.1512.87%-28.65%
Oct 14, 2024Michael ChernyBank of America Securities$23.00$19.8315.99%-34.36%
Oct 14, 2024Jailendra SinghTruist Financial$23.00$19.8315.99%-34.36%
Sep 13, 2024Allen LutzBank of America Securities$20.00$15.8226.42%-42.92%
Aug 27, 2024Daniel GrosslightCitigroup$20.00$14.9333.96%-42.92%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Apr 02, 2025CitigroupSellSellhold
Mar 06, 2025CitigroupSellSellhold
Feb 25, 2025NeedhamBuyBuyhold
Feb 19, 2025Canaccord GenuityBuyBuyhold
Jan 10, 2025CitigroupNeutralSelldowngrade
Dec 20, 2024UBSUnderperformUnderperformhold
Dec 02, 2024Canaccord GenuityBuyBuyhold
Nov 05, 2024NeedhamBuyBuyhold
Oct 29, 2024Leerink PartnersMarket PerformMarket Performhold
Oct 21, 2024NeedhamUnderperformUnderperformhold

Financial Forecast

EPS Forecast

Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-0.51$-0.58$-0.32$-0.11$0.58----
Avg Forecast$-0.28$-0.36$-0.32$-0.13$0.54$0.52$0.72$0.84$0.56
High Forecast$-0.26$-0.34$-0.28$-0.11$0.58$0.70$0.98$1.19$0.62
Low Forecast$-0.30$-0.40$-0.35$-0.15$0.50$0.28$0.39$0.45$0.46
Surprise %82.14%61.11%--15.38%7.41%----

Revenue Forecast

$0 $700M $1B $2B $3B $4B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$148.76M$271.88M$526.92M$872.00M$1.48B----
Avg Forecast$144.28M$264.20M$520.90M$871.89M$1.46B$2.04B$2.35B$2.74B$2.83B
High Forecast$154.07M$282.12M$557.08M$872.88M$1.47B$2.21B$2.36B$2.78B$3.06B
Low Forecast$136.46M$249.87M$469.87M$870.58M$1.45B$1.78B$2.34B$2.70B$2.46B
Surprise %3.10%2.90%1.15%0.01%1.12%----

Net Income Forecast

$-150M $-70M $10M $90M $170M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.11M$-107.66M$-65.68M$-23.55M$126.04M----
Avg Forecast$-57.85M$-108.55M$-67.50M$-23.55M$113.41M$120.85M$172.21M$238.96M$117.23M
High Forecast$-53.77M$-86.84M$-58.90M$-18.84M$121.66M$146.94M$204.73M$248.44M$129.47M
Low Forecast$-62.95M$-130.26M$-73.59M$-28.26M$105.16M$58.78M$81.25M$94.80M$97.17M
Surprise %-68.69%-0.82%-2.69%-11.14%----

HIMS Forecast FAQ

Is Hims & Hers Health stock a buy?

Hims & Hers Health stock has a consensus rating of Hold, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 7 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Hims & Hers Health is a neutral investment for most analysts.

What is Hims & Hers Health's price target?

Hims & Hers Health's price target, set by 14 Wall Street analysts, averages $39 over the next 12 months. The price target range spans from $21 at the low end to $68 at the high end, suggesting a potential 11.30% change from the previous closing price of $35.04.

How does Hims & Hers Health stock forecast compare to its benchmarks?

Hims & Hers Health's stock forecast shows a 11.30% upside, outperforming the average forecast for the consumer defensive stocks sector (8.69%) and outperforming the household & personal products stocks industry (9.51%).

What is the breakdown of analyst ratings for Hims & Hers Health over the past three months?

  • April 2025: 7.14% Strong Buy, 28.57% Buy, 50.00% Hold, 7.14% Sell, 7.14% Strong Sell.
  • March 2025: 13.33% Strong Buy, 26.67% Buy, 46.67% Hold, 6.67% Sell, 6.67% Strong Sell.
  • February 2025: 15.38% Strong Buy, 23.08% Buy, 46.15% Hold, 7.69% Sell, 7.69% Strong Sell.

What is Hims & Hers Health’s EPS forecast?

Hims & Hers Health's average annual EPS forecast for its fiscal year ending in December 2025 is $0.52, marking a -10.34% decrease from the reported $0.58 in 2024. Estimates for the following years are $0.72 in 2026, $0.84 in 2027, and $0.56 in 2028.

What is Hims & Hers Health’s revenue forecast?

Hims & Hers Health's average annual revenue forecast for its fiscal year ending in December 2025 is $2.04B, reflecting a 38.45% increase from the reported $1.48B in 2024. The forecast for 2026 is $2.35B, followed by $2.74B for 2027, and $2.83B for 2028.

What is Hims & Hers Health’s net income forecast?

Hims & Hers Health's net income forecast for the fiscal year ending in December 2025 stands at $120.85M, representing a -4.12% decrease from the reported $126.04M in 2024. Projections indicate $172.21M in 2026, $238.96M in 2027, and $117.23M in 2028.